Table 3. Projected absorbed organ doses of 89Zr-DFO-nimotuzumab.
| Organ | Female – 89Zr absorbed dose (cGy/mCi) | Male 89Zr absorbed dose (cGy/mCi) |
|---|---|---|
| Adrenals | 0.672 | 0.821 |
| Brain | 0.205 | 0.234 |
| Breasts | 0.573 | 0.601 |
| Gallbladder Wall | 1.07 | 1.30 |
| Lower Large Intestine | 0.757 | 0.779 |
| Small Intestine | 0.929 | 0.954 |
| Stomach | 0.693 | 0.783 |
| Upper Large Intestine | 0.882 | 0.936 |
| Heart Wall | 0.601 | 0.683 |
| Kidneys | 0.603 | 0.775 |
| Liver | 1.82 | 2.64 |
| Lungs | 0.481 | 0.557 |
| Muscle | 0.485 | 0.513 |
| Ovaries | 0.656 | |
| Pancreas | 0.636 | 0.819 |
| Red Marrow | 0.59 | 0.624 |
| Osteogenic Cells | 0.895 | 0.918 |
| Skin | 0.445 | 0.462 |
| Spleen | 0.431 | 1.93 |
| Testes | 0.402 | |
| Thymus | 0.452 | 0.473 |
| Thyroid | 0.618 | 0.623 |
| Urinary Bladder | 0.639 | 0.643 |
| Uterus | 0.564 | |
| Total Body | 0.624 | 0.677 |
| Effective dose (rem/mCi) | 0.679 | 0.757 |